Searched for
INSULIN INJECTION
26-year-old died overnight, once he tried to ‘outsmart’ his ‘slow killer’ disease, doctor reveals one habit which killed him: ‘He started taking oral…’Unchecked diabetes poses a severe risk, potentially leading to fatal outcomes if ignored. A young man's decision to avoid insulin injection...- Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increaseNovo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to ...
- Novo Nordisk readies once-a-week insulin shot for Indian marketNovo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment drastically cuts do...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Insurer denies Rs 20 lakh life insurance claim over diabetes non-disclosure; woman fights back and wins; here’s whyA Delhi woman's Rs 20 lakh life insurance claim, denied due to alleged non-disclosure of diabetes and kidney diseases, was upheld by the St...
- Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...
- Struggling with Type 2 diabetes? Doctors reveal natural ways to lower insulinType 2 diabetes can be managed naturally with a healthy diet and regular exercise. Eating more vegetables, lean protein, and healthy carbs ...
- ET Explains: Cure to Type-1 Diabetes offers hope, but exercise cautionChinese scientists claim a potential cure for type-1 diabetes through cell transplants, allowing a patient to stop insulin injections for a...
- Novo Nordisk gets approval to carry out clinical trials on weekly insulinNovo Nordisk has received approval from the Drug Controller General of India to conduct phase-III studies for its new weekly insulin inject...
- AIIMS adds 63 drugs to free medicine list"Sixty-three medicines have been added to the existing list," Dr M Srinivas said. Palbociclib, Dasatinib, Methotrexate, Trimazet, Magestero...
- Biocon's interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in USThe listing is expected to boost Biocon's biosimilar business, as inclusion of Semglee on Express Scripts' NPF will allow pharmacies to sub...
- How insulin therapy is proving to be a boon for type-1 diabeticsHowever, improper choice of injection site, technique including reuse of needles might lead to compromised outcomes.
- New type of engineered insulin to treat diabetesThe advance could eliminate the need for diabetics to repeatedly monitor their blood sugar levels and inject insulin throughout the day, sa...
- Novo Nordisk to launch insulin injection Tresiba in IndiaInsulin player Novo Nordisk said it is launching long-lasting insulin injection Tresiba in the country soon.
- Coming soon: Novo Nordisk’s long-lasting insulin injectionNovo is betting big on Tresiba in the emerging markets after it failed to get an approval for the drug from the US Food and Drug Administra...
- NPPA asked to revisit decision on prices for insulin: Srikant Kumar JenaThe DoP has asked NPPA to revisit the decision of fixing ceiling prices of various insulin formulations in the wake of review applications ...
- Novo Nordisk to rope in health workers for diabetes care to poorSeveral diabetic patients require insulin injections on a life-long basis, and it is difficult for the economically under-privileged to qui...
- Biocon to launch oral insulin drug by 2010Biotech company Biocon is planning to launch its oral insulin drug in India by 2010 and is targeting sales of Rs 500 crore from the domesti...
- Biocon to launch oral insulin drug by 2010Biotech company Biocon is planning to launch its oral insulin drug in India by 2010 and is targeting sales of Rs 500 crore from the domesti...
Load More
